A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2002
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090510A2 Regulating immine responses using dendritic cells
11/14/2002	WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	WO2002090502A2 Highly conserved proteins from gram-positive bacteria
11/14/2002	WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/14/2002	WO2002090383A2 M. catarrhalis antigens
11/14/2002	WO2002090382A2 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
11/14/2002	WO2002089858A1 Azo compounds for type i phototherapy
11/14/2002	WO2002089842A1 Combination therapy using anti-egfr antibodies and anti-hormonal agents
11/14/2002	WO2002089841A2 Method of preventing cell death using antibodies to neural thread proteins
11/14/2002	WO2002089840A1 Recombinant bicistronic flaviviruses and methods of use thereof
11/14/2002	WO2002089839A1 Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella catarrhalis
11/14/2002	WO2002089838A1 Saponin inactivated mycoplasma vaccine
11/14/2002	WO2002089837A1 Chimeric human leukocyte antigen and epitope-bearing molecules having immunosuppressant activity
11/14/2002	WO2002089834A1 Bont/e or snap-25e for treating botulinum toxin a or c1 poisoning and inhibiting muscle contraction
11/14/2002	WO2002089832A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	WO2002089805A2 Use of regularly scheduled high dose intravenous methotrexate therapy
11/14/2002	WO2002089796A2 Methods for selective immunomodulation using pimecrolimus
11/14/2002	WO2002089762A1 Concentrated w/o emulsion
11/14/2002	WO2002089747A2 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	WO2002089733A2 Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications
11/14/2002	WO2002089731A2 Agents for treatment of hcv and methods of use
11/14/2002	WO2002089615A2 Anti-ige antibody to treat ocular allergies
11/14/2002	WO2002089586A1 Lung epithelial cell line for propagating viruses
11/14/2002	WO2002070679A3 Peptide fragments, derived from human telomerase reverse transcriptase
11/14/2002	WO2002068457A3 Antiangiogenic peptides derived from endostatin
11/14/2002	WO2002062370A3 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
11/14/2002	WO2002061081A9 A novel gene bn01 mapping to chromosome 16q24.3
11/14/2002	WO2002060376A3 Induction of tolerance by apoptotic and/or necrotic cells
11/14/2002	WO2002051233A3 Universal antimicrobial treatment
11/14/2002	WO2002050116A3 Adhesion molecule protein
11/14/2002	WO2002032944A3 Basb208 nucleotide and amino acid sequences from haemophilus influenzae
11/14/2002	WO2002028906A3 Regulation of human sphingosine kinase-like protein
11/14/2002	WO2002016440A8 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections
11/14/2002	WO2002009746A8 Vaccines comprising outer membrane vesciles from gram negative bacteria
11/14/2002	WO2001021636A9 Identification of a vaccine candidate from an extraintestinal isolate of e. coli
11/14/2002	US20020169305 Nucleotide sequences coding polypeptide for use in the treatment and prevention of malaria
11/14/2002	US20020169288 Therapeutic composition for treating or preventing staphylococcal infection
11/14/2002	US20020169285 Polypeptide for use in the diagnosis, prevention and treatment of protozoan infections
11/14/2002	US20020169284 Nucleotide sequences coding polypeptide for use in the treatment of tumors, nervous system, virus, and visoin disorders
11/14/2002	US20020169264 Acylation with an acryloyl group of an amino group at some point in the peptide sequence, while still attached to the solid phase support with side chain groups intact, followed by deprotecting and free radical polymerization; vaccines
11/14/2002	US20020169165 Substituted bicyclic derivatives for the treatment of abnormal cell growth
11/14/2002	US20020169136 For detection of Babesia microti infection; in particular, invention is antigenic epitopes of such an antigen and the use of such polypeptides and antigenic epitopes for the serodiagnosis and treatment of B. microti infection
11/14/2002	US20020169132 Polypeptides
11/14/2002	US20020169117 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/14/2002	US20020169116 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/14/2002	US20020169115 Method of predicting resistance to hepatitis C infection
11/14/2002	US20020168728 Generation preferential proteins; obtain gram-negative prokaryotic cell, transform with nucleotide sequences coding protein, culture, recover protein
11/14/2002	US20020168727 Generation of botulinum neurotoxin light chain; culture cells coding botulinum neurotoxin light chain, express genes, recover protein
11/14/2002	US20020168726 Bacterial antigens and vaccine compositions
11/14/2002	US20020168717 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer
11/14/2002	US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002	US20020168712 Molecules designated LDCAM
11/14/2002	US20020168710 Anticancer agents; cardiovascular disorders; anticholesterol agents
11/14/2002	US20020168696 Annexin proteins and autoantibodies as serum markers for cancer
11/14/2002	US20020168695 Detecting cell proliferative disorder in humans; obtain tissue sample, incubate with probe, detect signal from tissue sample, signal indicates cancer
11/14/2002	US20020168690 Peptide for use in the treatment of arthritis
11/14/2002	US20020168662 Sperm protein 17 for the diagnosis and treatment of cancer
11/14/2002	US20020168628 Variant of LAV viruses
11/14/2002	US20020168427 Plant extract
11/14/2002	US20020168385 Adeno-associated virus vector for boosting immunogenicity of cells
11/14/2002	US20020168384 Vaccine for poultry respiratory disorders
11/14/2002	US20020168383 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response
11/14/2002	US20020168382 Inducing immunology response
11/14/2002	US20020168380 Moderating immunology response
11/14/2002	US20020168379 Veterinary medicine; swine respiratory system disorders
11/14/2002	US20020168377 Prion protein dimers useful for vaccination
11/14/2002	US20020168376 Plant extracts; sensitization of an animal; screening
11/14/2002	US20020168375 Biosynthetic binding proteins for immuno-targeting
11/14/2002	US20020168374 Hla binding peptides and their uses
11/14/2002	US20020168373 House dust mite allergen, Der f VII, and uses therefor
11/14/2002	US20020168371 Process for reducing antibody response against xenografts
11/14/2002	US20020168366 Administering a binding agent capable of binding platelets binding platelets to the binding agent to form captured platelets, inducing activation of the captured platelets and forming a thrombus, which provides therapeutic benefit
11/14/2002	US20020168362 Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
11/14/2002	US20020168361 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit
11/14/2002	US20020168360 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphanubeta3 antagonists in combination with other prophylactic or therapeutic agents
11/14/2002	US20020168357 Administering to a mammal an antibody capable of binding native tissue factor, and linked covalently to a cell antigen or an effector molecule to provide complement fixing ability and antibody dependent cell mediated cytotoxicity
11/14/2002	US20020168356 An antibody capable of binding a PF4AR (platelet factor 4 superfamily member) polypeptide and the polypeptide is an interleukin-8 receptor; antiinflammatory agent
11/14/2002	US20020168351 Fusion cells and cytokine compositions for treatment of disease
11/14/2002	US20020168348 Prolonging the acceptance of a graft by administering a short course of an immunosuppressant
11/14/2002	US20020168347 Monocyte derived cells, in a purified form, presenting antigenic epitopes on their membranes after interioriztion and processing of an antigen-antibody complex, such epitope corresponding to proteolytic degradation product of antigen
11/14/2002	US20020168345 Methods of monitoring HIV drug resistance using adenoviral vectors
11/14/2002	CA2483658A1 Bont/e or snap-25e for treating botulinum toxin a or c1 poisoning and inhibiting muscle contraction
11/14/2002	CA2449166A1 Combination therapy using anti-egfr antibodies and anti-hormonal agents
11/14/2002	CA2447360A1 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	CA2446788A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	CA2446640A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same
11/14/2002	CA2446480A1 Method of preventing cell death using antibodies to neural thread proteins
11/14/2002	CA2446458A1 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	CA2446437A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	CA2446355A1 Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella catarrhalis
11/14/2002	CA2446294A1 Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them
11/14/2002	CA2446087A1 Recombinant tumor specific antibody and use thereof
11/14/2002	CA2446062A1 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
11/14/2002	CA2446036A1 A method for transfection of rna using electrical pulses
11/14/2002	CA2445997A1 Saponin inactivated mycoplasma vaccine
11/14/2002	CA2445982A1 Sperm-specific cation channel, and uses therefor
11/14/2002	CA2445269A1 Anti-ige antibody to treat ocular allergies
11/14/2002	CA2442969A1 Methods for selective immunomodulation using pimecrolimus
11/14/2002	CA2435142A1 Kinases and phosphatases

1 ... 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 ... 1823